SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: medsunman who wrote (24106)8/6/1998 7:27:00 PM
From: Henry Niman  Respond to of 32384
 
medsunman, thanks for the heads up. I had said something to that effect previously, but someone uploaded a dermatology article about decrease KS incidences. At LGND's website, they indicate that many KS patients go untreated because they are already taking many medications and KS therapies involve IVs. Panretin of course is easily taken, either via a topical gel or an oral capsule.